The global market for micro servers is observing massive call for competent computing goods, which has obliged market players to upturn their concentration on product invention and development of the current assortment. Mergers, acquisit…
BMI View: On the back of robust economic expansion, Cameroon's pharmaceuticals and healthcare sector
will continue experience high growth rates over the forecast period. As the drug market continues to
expand, and spending per capita on medicine increases from its current low base, Cameroon will slowly
improve its appeal to foreign pharmaceutical operators. For example, this is illustrated by Algerian Saidal
group recent announcement to begin exporting medicines to Cameroon. That said, Cameroon will continue
to represent a high risk market to foreign drugmakers, with a poor operating environment and the persistent
presence of counterfeit drugs in the country acting as significant challenges.
Headline Expenditure Projections
? Pharmaceuticals: XAF217.14bn (USD370mn) in 2015 to XAF236.33bn (USD390mn) in 2016; +8.8%
in local currency terms and +5.0% in US dollar terms. Forecast revised slightly downwards from last
? Healthcare: XAF694.93bn (USD1.17bn) in 2015 to XAF729.62bn (USD1.19bn) in 2016; +5.0% in local
currency terms and +1.3% in US dollar terms. Forecast broadly in line with last quarter.